PHARMACOEPIDEMIOLOGIC ANALYSIS OF HOSPITAL TREATMENT OF PATIENTS WITH CEREBRAL INFARCTION AND ATRIAL FIBRILLATION

PHARMACOEPIDEMIOLOGIC ANALYSIS OF HOSPITAL TREATMENT OF PATIENTS WITH CEREBRAL INFARCTION AND ATRIAL FIBRILLATION

Show other versions (1)

Aim. To analyze pharmacotherapy of cerebral infarction in patients with atrial fibrillation (AF) in real clinical practice of neurological departments of Saratov hospitals.Material and methods. A retrospective longitudinal pharmacoepidemiologic study was carried out. Medical cards were analyzed in p...

Full description

Bibliographic Details
Main Authors:	N. V. Mikheeva, O. V. Reshetko, N. V. Furman
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-09-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	cerebral infarction atrial fibrillation pharmacoepidemiology antithrombotic agents secondary prevention
Online Access:	https://www.rpcardio.online/jour/article/view/291

Similar Items

Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis)
by: O. V. Reshetko, et al.
Published: (2020-11-01)

ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY)
by: V. I. Petrov, et al.
Published: (2015-09-01)

Pharmacoepidemiology of stroke treatment in different hospitals
by: N. V. Mikheeva, et al.
Published: (2015-03-01)

Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation
by: V. I. Petrov, et al.
Published: (2019-03-01)

UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION
by: E. A. Protasova, et al.
Published: (2015-12-01)

PHARMACOEPIDEMIOLOGICAL ANALYSIS OF THE TREATMENT OF PAROXYSMAL AND PERSISTENT ATRIAL FIBRILLATION IN EVERY DAY CLINICAL PRACTICE
by: I. V. Graifer, et al.
Published: (2016-01-01)

Managing antithrombotic treatment in a patient with atrial fibrillation and coronary stent with transient neurological symptoms in cerebral amyloid angiopathy
by: Julie Ravn, et al.
Published: (2022-12-01)

RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE
by: I. V. Grajfer, et al.
Published: (2015-12-01)

PHARMACOEPIDEMIOLOGIC ANALYSIS OF HOSPITAL TREATMENT OF PATIENTS WITH CEREBRAL INFARCTION AND ATRIAL FIBRILLATION
by: N. V. Mikheeva, et al.
Published: (2015-09-01)

ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS
by: A. Y. Rychkov, et al.
Published: (2016-01-01)

PHARMACOEPIDEMIOLOGIC ANALYSIS OF ST-ELEVATION MYOCARDIAL INFARCTION REPERFUSION THERAPY AT SARATOV REGION HOSPITALS OF DIFFERENT TYPES
by: O. V. Reshetko, et al.
Published: (2016-01-01)

Changes in prescribing antithrombotic therapy in patients with atrial fibrillation and myocardial infarction in 2016-2019
by: K. G. Pereverzeva, et al.
Published: (2020-08-01)

The safety of antithrombotic therapy in patients with cerebral microbleeds and cardiogenic cerebral embolism due to nonvalvular atrial fibrillation
by: Jiayu Wang, et al.
Published: (2019-04-01)

Antithrombotic therapy and its impact on prognosis in patients with atrial fibrillation and myocardial infarction. Long-term observation results
by: Mariia V. Soloveva, et al.
Published: (2021-10-01)

The influence of clinical and medical history factors and anti-thrombotic therapy on the prognosis in patients with atrial fibrillation and myocardial infarction
by: Kristina G. Pereverzeva, et al.
Published: (2022-07-01)

Oral anticoagulant therapy for patients with new-onset atrial fibrillation following acute myocardial infarction: A narrative review
by: Shenglong Yu, et al.
Published: (2022-11-01)

High Mortality Rates Among Patients With Non‐Traumatic Intracerebral Hemorrhage and Atrial Fibrillation on Antithrombotic Therapy Are Independent of the Presence of Cerebral Amyloid Angiopathy: Insights From a Population‐Based Study
by: Shiva P. Ponamgi, et al.
Published: (2020-08-01)

Neonatal Cerebral Infarction and Neuromotor Dysfunction
by: J Gordon Millichap
Published: (2004-02-01)

The antithrombotic therapy of atrial fibrillation in patients with coronary heart disease
by: Olga L. Bockeria, et al.
Published: (2018-11-01)

RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION
by: M. Yu. Gilyarov
Published: (2015-12-01)

THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY
by: M. Yu. Gilyarov
Published: (2015-12-01)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES
by: Ya. P. Dovgalevskiy, et al.
Published: (2016-01-01)

PROSPECTS FOR THE TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION
by: V. A. Sulimov, et al.
Published: (2016-01-01)

The quality of prior antithrombotic therapy and the severity of ischemic stroke in atrial fibrillation
by: L. A. Geraskina, et al.
Published: (2020-10-01)

Association Rules to Identify Complications of Cerebral Infarction in Patients with Atrial Fibrillation
by: Sun-Ju Jung, et al.
Published: (2013-03-01)

Embolic myocardial infarction. Literature review and own research results
by: S. A. Boldueva, et al.
Published: (2020-07-01)

Statins in Secondary Prevention of Atrial Fibrillation
by: V. I. Podzolkov, et al.
Published: (2016-11-01)

Prior Antithrombotic Therapy Is Associated With Cerebral Microbleeds in Ischemic Stroke Patients With Atrial Fibrillation and/or Rheumatic Heart Disease
by: Yajun Cheng, et al.
Published: (2019-01-01)

Effect of frailty syndrome on the risk of myocardial infarction and atrial fibrillation
by: A. V. Turusheva, et al.
Published: (2023-07-01)

Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation – results from the GARFIELD-AF registry
by: Marita Knudsen Pope, et al.
Published: (2021-01-01)

Effects of sufficient anticoagulation on ischemic stroke outcomes in patients with nonvalvular atrial fibrillation
by: Tae Jung Kim, et al.
Published: (2023-12-01)

COMBINED ANTITHROMBOTIC THERAPY IN CASE OF PLANNED PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ATRIAL FIBRILLATION IN ACTUAL CLINICAL PRACTICE
by: N. Yu. Khorkova, et al.
Published: (2018-12-01)

THE EVALUATION OF ANTITHROMBOTIC TREATMENT PRESCRIPTION DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION BY THE DATA OF PROFILE REGISTRY
by: S. Yu. Martsevich, et al.
Published: (2015-02-01)

Use of Oral Anticoagulant for Secondary Prevention of Stroke in Very Elderly Patients With Atrial Fibrillation: An Observational Study
by: Ya-Ju Lin, et al.
Published: (2011-03-01)

Antithrombotic therapy in very elderly patients with atrial fibrillation: Is it enough to assess thromboembolic risk?
by: Yutao Guo, et al.
Published: (2010-05-01)

Fact-finding survey of antithrombotic treatment for prevention of cerebral and systemic thromboembolism in patients with non-valvular atrial fibrillation in 9 countries of the Asia-Pacific region
by: Satoshi Ogawa, et al.
Published: (2012-02-01)

SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY)
by: S. B. Fitilev, et al.
Published: (2017-05-01)

Pharmacoepidemiology /
by: Strom, Brian L.
Published: (2005)

AGE AND EFFECTIVENESS AND SAFETY OF VARIOUS ANTITHROMBOTIC THERAPY VARIANTS IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION
by: V. I. Shevelev, et al.
Published: (2013-02-01)

Rivaroxaban Monotherapy in Patients With Atrial Fibrillation and Coronary Stenting at Multiple Vessels or the Left Main Trunk: The AFIRE Trial Subanalysis
by: Mitsuru Ishii, et al.
Published: (2022-11-01)